Oarsman Capital Inc. Sells 95 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Oarsman Capital Inc. trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.1% during the fourth quarter, HoldingsChannel reports. The firm owned 1,475 shares of the biotechnology company’s stock after selling 95 shares during the quarter. Oarsman Capital Inc.’s holdings in Axon Enterprise were worth $877,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in AXON. Public Sector Pension Investment Board lifted its stake in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. Friedenthal Financial grew its position in shares of Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after purchasing an additional 1,231 shares in the last quarter. Principal Financial Group Inc. boosted its stake in Axon Enterprise by 33.1% in the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after purchasing an additional 33,869 shares during the period. XTX Topco Ltd lifted its holdings in shares of Axon Enterprise by 20.6% in the third quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock worth $2,258,000 after buying an additional 964 shares in the last quarter. Finally, Artemis Investment Management LLP boosted its position in shares of Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock valued at $56,528,000 after acquiring an additional 16,792 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on AXON. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Activity

In related news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $497.13 on Friday. The firm has a fifty day simple moving average of $582.26 and a two-hundred day simple moving average of $553.47. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a market capitalization of $38.09 billion, a PE ratio of 128.46, a P/E/G ratio of 5.17 and a beta of 1.13. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.